Modernavs.Vertex Pharmaceuticals
MRNA vs VRTX · both in Biotech & innovation, part of the Medicine, pharma & life science value chain: Innovation-driven biotech companies focused on novel treatment modalities.
Vertex Pharmaceuticals is about 4.5× larger than Moderna by market cap; year to date, Moderna leads (+131.5% vs +7.1%).
Side by side
| MRNA | VRTX | |
|---|---|---|
| Market cap | $27.2B | $121B |
| Price | $68.27 | $485.39 |
| Today | −10.8% | −2.2% |
| Return YTD | +131.5% | +7.1% |
| Return 1Y | +99.2% | +1.2% |
| P/E | — | 27.9 |
| P/S | 12.2 | 9.9 |
| P/B | 3.7 | 6.3 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
ModernaMRNA
American biotech company based on mRNA technology — known for the covid vaccine, with a pipeline in vaccines and oncology.
Full MRNA profile →Vertex PharmaceuticalsVRTX
American biotech company and global leader in cystic fibrosis treatment, with a pipeline in pain and gene therapy.
Full VRTX profile →More comparisons in Biotech & innovation
See where MRNA and VRTX sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →